Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:30 PM
Ignite Modification Date:
2025-12-24 @ 2:30 PM
NCT ID:
NCT00776659
Eligibility Criteria:
Inclusion Criteria:
* Patients with early breast cancer receiving adjuvant therapy with Aromasin® will be eligible.
Exclusion Criteria:
* Patients presenting with in situ cancers, recurrent or metastatic breast cancer, or a 2nd primary will not be included.
* Patients with a known hypersensitivity to Exemestane or its metabolites will also not be included.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00776659
Study Brief:
Protocol Section:
NCT00776659